Skip to content
Unrated Drug recall · FDA · Published October 21, 2025

TYLENOL Extra Strength 24 Caplets Recall: Defective Container Hazard

Kenvue recalls TYLENOL Extra Strength 24 caplets (NDC 50580-378-04) due to defective container. Consumers should check lot number EJA022 and expiry 04/30/2028 for affected units.

🇺🇸 FDA recall #D-0121-2026DrugKenvue ›
Take action

Contact the company

Recalling firmKenvue Brands LLC1 Kenvue Way · Summitt, NJ 07901
✎ GovInfoNow plain-language explainer

Kenvue is recalling TYLENOL Extra Strength 24 caplet bottles with a defective container. This could lead to injury if the container fails during use. Affected products have lot number EJA022 and expire 04/30/2028. Read more at govinfonow.com/recall/31684-tylenol-extra-strength-24-caplets-recall-defective-container-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/31684-tylenol-extra-strength-24-caplets-recall-defective-container-hazard · Updated August 17, 2026 · FDA enforcement record: FDA #D-0121-2026

Cite this page

“TYLENOL Extra Strength 24 Caplets Recall: Defective Container Hazard.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31684-tylenol-extra-strength-24-caplets-recall-defective-container-hazard. Based on FDA recall #D-0121-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0121-2026%22&limit=1).

The FDA announced on Oct. 21, 2025, that Kenvue Brands LLC voluntarily recalled TYLENOL Extra Strength 24 Caplets due to a defective container hazard. The recall affects 3,816 bottles distributed nationwide and in Colorado, Illinois, Ohio, and Indiana.

How to tell if you have it

  • Brand: Kenvue
  • Product: TYLENOL, Acetaminophen, Extra Strength, 24 Caplets, 500mg each
  • Distributor: Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
  • NDC: 50580-378-04
  • Lot: EJA022
  • Expiry: 04/30/2028
  • Quantity: 3,816 bottles

The hazard

The recall is due to a defective container. The FDA classified the recall as Class II.

Context

GovInfoNow's records show Kenvue has faced other regulatory actions, including recent recalls of similar products such as Apotex Desmopressin Nasal Spray (2026-04-08), Keystone Burkhart Anesthetic Gel (2026-05-21), and Kirkman MAXIMUM Lidocaine Cream (2026-02-18). FDA's FAERS database contains 272,726 adverse-event reports naming this product across all years, with 229,187 marked serious and 50,785 listing a death.

How to tell if you have this one

Check for the lot number EJA022 and expiry date 04/30/2028 on the product label. The product is labeled as TYLENOL Acetaminophen Extra Strength 24 Caplets, 500mg each.

  • Brand
    Kenvue
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot number EJA022 and expiry date 04/30/2028 on the container.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 4 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: named in the noticeCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: nationwideTXFlorida: nationwideFL

FDA distribution: “U.S. Nationwide - CO, IL, OH and IN.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Colorado, Illinois, Indiana, Ohio.

Recall timeline

FDA published this recall 15 days after the firm started it.

1. Firm started the recall: Oct 21, 202512. FDA classified it Class II: Oct 28, 202523. Published in FDA’s Enforcement Report: Nov 5, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0121-2026 (October 21, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0121-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA